Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1-13) and D-Ala2-dynorphin-(1-11) in rats.
D000700:Analgesics; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D002375:Catalepsy / Q000139:chemically induced; D004399:Dynorphins; D004723:Endorphins / Q000494:pharmacology*; D004745:Enkephalins / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D008297:Male; D010446:Peptide Fragments / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D013329:Structure-Activity Relationship
D000700:Analgesics; D004723:Endorphins; D004745:Enkephalins; D010446:Peptide Fragments; C026843:dynorphin (1-13); D004399:Dynorphins; C026844:dynorphin (1-11), Ala(2)-